Luster MI, Germolec DR, Parks CG, Blaciforti L, Kashon M, Luebke R. Associating changes in the immune system with clinical diseases for interpretation in risk assessment.
Curr Protoc Toxicol 2004;
Chapter 18:Unit18.1. [PMID:
23045101 PMCID:
PMC7162383 DOI:
10.1002/0471140856.tx1801s20]
[Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
This overview unit discusses the relationship between immunosuppression, a potential consequence of immunotoxicity, and disease progression. It also discusses other factors, such as stress and age, that affect disease susceptibility. These factors play an important role in risk assessment for exposures to environmental factors.
Collapse